secwatch.observer — SEC 8-K summary
======================================

Issuer:     Estrella Immunopharma, Inc. (ESLA)
CIK:        0001844417
Form:       8-K
Filed at:   2025-08-07T23:59:59+00:00
Accession:  0001213900-25-072746
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Estrella Immunopharma receives Nasdaq non-compliance notice for MVLS below $35M
-------------------------------------------------------------------------------

- Received Nasdaq notice on Aug 1, 2025 for failing to maintain minimum MVLS of $35M for 30 consecutive business days.
- Non-compliance period identified as June 13, 2025 to July 31, 2025.
- Company has 180 days, until Jan 28, 2026, to regain compliance with MVLS of $35M+ for 10 consecutive business days.
- Also noted non-compliance with alternative listing rules 5550(b)(1) and 5550(b)(3).
- No immediate effect on listing; Company will monitor and consider options but cannot assure regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844417/000121390025072746/0001213900-25-072746-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844417/000121390025072746/ea0252082-8k_estrella.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-072746

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer